Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.65B
Enterprise Value8.92B
P/E Ratio-122.99
PEG Ratio-0.18
Price/Sales Ratio5.84
Price/Book Ratio2.62
Enterprise/Revenue6.16
Enterprise/EBITDA-166.21

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.13
Operating Margin-0.1
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.06

Income Statement

Revenue1.12B
Revenue/Share1.89
Gross Profit1.14B
EBITDA-23.08M
Net Income-167.24M
Diluted EPS-0.32

Balance Sheet

Total Cash568.77M
Total Cash/Share0.93
Total Debt942.34M
Total Debt/Equity0.37
Current Ratio1.28
Book Value Per Share4.35

Price History

52-Week Change-28.07
52-Week High36.24
52-Week Low8.53
Moving Average 50 Days10.85
Moving Average 200 Days16.15

Statistics

Average Volume14.07M
Shares Outstanding611.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.26
Last Split Factor8:5
Last Split DateJune 10, 2008
AD